<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the effects of <z:chebi fb="1" ids="26308">propyl</z:chebi> <z:chebi fb="0" ids="16918">gallate</z:chebi> (PrG) on the <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation time and the coagulation/fibrinolysis system in an experimental carotid artery <z:mp ids='MP_0005048'>thrombosis</z:mp> model in rats </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Fifty SD rats were randomly divided into 5 groups (10 animals/group): the <z:mpath ids='MPATH_458'>normal</z:mpath> group (<z:mpath ids='MPATH_458'>normal</z:mpath> saline 2 mL/kg), the model group (<z:mpath ids='MPATH_458'>normal</z:mpath> saline, 2 mL/kg), the <z:chebi fb="5" ids="28304">heparin</z:chebi> control group (1,250 IU/kg), the low dose PrG group (30 mg/kg), and the high dose PrG group (60 mg/kg) </plain></SENT>
<SENT sid="2" pm="."><plain>Thirty minutes after intravenous injection of saline or the corresponding drugs, a carotid artery <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> was induced by continuous electric stimulation in <z:hpo ids='HP_0000001'>all</z:hpo> rats except for those in the <z:mpath ids='MPATH_458'>normal</z:mpath> group </plain></SENT>
<SENT sid="3" pm="."><plain>The duration from the initiation of the electric stimulation to the sudden drop in carotid temperature was recorded as the <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation time </plain></SENT>
<SENT sid="4" pm="."><plain>Levels of plasma tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) were determined by ELISA </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: PrG (30 and 60 mg/kg) can prolong the <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation time, but the effect was obviously weaker than that of <z:chebi fb="5" ids="28304">heparin</z:chebi> (P&lt;0.05, P&lt;0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>Compared with the model group, PrG (30 and 60 mg/kg) elevated the plasma activity of t-PA (both P&lt;0.05) and showed an increasing tendency in elevating the ratio of t-PA/PAI-1 (P&gt;0.05), while it had no significant effect on the level of PAI-1 </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: PrG has a certain antithrombotic effect and can slightly regulate the imbalance of the t-PA /PAI-1 ratio </plain></SENT>
</text></document>